Latest Headlines
State Council Promises Severe Punishment on Substandard Vaccine Making, Vowing Institutional Safeguards for Drug Safety
  ·  2018-08-01  ·   Source:

Changsheng Life Sciences Ltd, held responsible for illegally producing sub-standard rabies vaccines for human use, will receive severe punishment, and a long-term institutional mechanism for safeguarding drug safety will be established in the country, as decided at the State Council's executive meeting on July 30.

The meeting, chaired by Premier Li Keqiang, heard report from the State Council's investigation team of its findings on the case of illegal production of rabies vaccines by Changsheng, which is located in Changchun city, Jilin Province.

The meeting on July 30 urged competent departments to work with local authorities to recall and destroy each and every dose of the problem vaccine that have not yet been put to use.

The meeting also called for government supervision for recalling of faulty vaccines that may have been exported by the company in question and for timely briefings made to the World Health Organization.

At the same time, thorough checks will be carried out on all the other vaccines produced by the company and any sub-standard cases uncovered will be dealt with immediately.

"The CPC central leadership and the State Council have placed high priority on tackling this case and so far the investigation has moved forward steadily," Li said, " Given the heinous nature of this incident, tough punishment must be meted out to the culprits, and a comprehensive plan be drawn up to deal with its aftermath."

So far, the investigation has found evidence that the company, in producing rabies vaccines for human use, has engaged in suspected criminal activities involving violations of approved production process, falsification of production and inspection records, and destruction of evidence, severely violating national drug standards and regulations.

The meeting on July 30 called for expeditious steps to impose stronger punishment and heavier fines on the company and those held accountable for the case in accordance with law, while State Council investigation group's work on the case will continue. Suspected criminals will be handed over to judicial authorities for prosecution. Those who gravely violated the law will receive jail sentences, and will be driven out of the pharmaceutical business for life.

At the same time, the government will speed up its sweeping inspections and checks on all 46 vaccine producers across China. The results will be made public in a timely fashion.

The meeting on July 30 called for a thorough investigation on possible misconduct in the regulation and supervision. Any dereliction of duty will be investigated and once established, severely punished. There will be zero tolerance for law-breaking activities such as bribe-taking and illegal transfer of benefits.

"Possible criminal activities of counterfeiting and administrative dereliction of duty will be thoroughly investigated and punished with the full rigor of the law. We must make this amply clear to our people and to the international community," Li noted at the meeting.

The meeting on July 30 also urged competent government agencies to move quickly in formulating a detailed regulatory plan that covers the entire process of vaccine R&D, production, distribution and use to set up institutional safeguards for drug safety

"As part of efforts to handle this incident, we must carry out sweeping checks on the vaccine business and indeed the entire drug industry, and put together a long-term mechanism for drug safety by drawing on advanced international practice," Li said.

He instructed that detailed and sound plans be worked out to deal with problems arising from the incident.

(Xinhua News Agency July 31, 2018)

China
Opinion
World
Business
Lifestyle
Video
Multimedia
 
China Focus
Documents
Special Reports
 
About Us
Contact Us
Advertise with Us
Subscribe
Partners: China.org.cn   |   China Today   |   China Pictorial   |   People's Daily Online   |   Women of China   |   Xinhua News Agency   |   China Daily
CGTN   |   China Tibet Online   |   China Radio International   |   Global Times   |   Qiushi Journal
Copyright Beijing Review All rights reserved 京ICP备08005356号 京公网安备110102005860